Lyn Finelli, DrPH, MS

Director, Vaccines
Merck & Co., Inc.
Kenilworth, NJ

Disclosure: Merck&Co.: Employee

Presentation(s):

• 92 - Incidence of Respiratory Syncytial Virus Infection among Hospitalized Adults, 2017-2019

  Thursday, October 3
  10:30 AM – 10:42 AM